Quercetin-loaded solid lipid nanoparticles for enhanced anti-helminthic activity.
Quercetin, a naturally occurring flavonoid, exhibits various anti-carcinogenic, anti-viral, anti-inflammatory properties, and anti-helminthic properties. Still, a major portion of orally administered quercetin is metabolized in the intestine and only little amount get absorbed in the portal veins, a...
| Published in: | International Journal of Pharmaceutics |
|---|---|
| Main Authors: | , , , , |
| Format: | Article in Journal/Newspaper |
| Language: | English |
| Published: |
Elsevier Science
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.ijpharm.2025.125308 https://pubmed.ncbi.nlm.nih.gov/39894091 |
| Summary: | Quercetin, a naturally occurring flavonoid, exhibits various anti-carcinogenic, anti-viral, anti-inflammatory properties, and anti-helminthic properties. Still, a major portion of orally administered quercetin is metabolized in the intestine and only little amount get absorbed in the portal veins, attributing to its poor bioavailability. The lipid content of food increases the solubility, which inspired us to fabricate lipid-based nanoparticles that will be biocompatible, orally administrable, and enhance the effectiveness of quercetin in hosts. Quercetin-loaded solid lipid nanoparticles (SLN-Qt) are spherical-shaped, water-soluble in nature, and nanocarriers having a hydrodynamic size of 130.7 ± 42.0 nm showing a drug entrapment efficiency of 79.75 % with sustained drug release of 37.5 ± 1.5 % within the first 24 h at pH 6.4. The drug release was observed till 6 days with 93.7 ± 3.0 % of drug release at pH 7.4. These results suggest improved drug entrapment, high saturation solubility, and better drug distribution. The in-vivo analysis was performed in house rats (Rattus rattus), which were found infected with Syphacia muris, Aspicularis tetraptera, Hymenolepis diminuta, Hymenolepis nana, Cysticercus fasciolaris, Calodium hepaticum, and/ or Trichuris muris. SLN-Qt (200 mg/Kg) treatment showed a significant reduction of parasite egg counts (85.09 ± 15.00 %) of gastrointestinal helminths after 3-dose weekly treatment. Liver histology and biochemical analysis of blood plasma and liver homogenate showed no toxic effects of quercetin and SLN-Qt. Therefore, SLN-Qt presents a promising strategy for delivering poorly soluble drugs and could be a valuable tool in controlling parasitic infections and diseases. |
|---|